Smoltek (SMOL) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
6 Jun, 2025Leadership transition and strategic direction
Magnus Andersson appointed as CEO effective June 1, 2025, signaling a shift toward commercialization and growth.
Andersson brings over 25 years of international experience in business development, acquisitions, and leadership in technology-driven companies, especially in the energy sector.
Outgoing CEO Håkan Persson will remain as senior advisor during the transition, after leading the company from research to industrialization readiness.
The board aims for Smoltek to become a global leader in ultra-thin capacitors and electrodes for green hydrogen, targeting a billion-dollar valuation.
Andersson highlights strong technical validation, ongoing licensing dialogues, and market interest as drivers for near-term revenue and shareholder value.
Business focus and market positioning
Smoltek specializes in nanotechnology-based products addressing advanced material engineering challenges in semiconductors and hydrogen sectors.
The company holds a robust patent portfolio with over 110 applications and 95 granted patents.
Current strategy emphasizes licensing deals and strategic partnerships to accelerate commercialization.
Investor presentation scheduled to outline the next phase of strategy and answer stakeholder questions.
Smoltek is listed on the Spotlight Stock Market under the ticker SMOL.
Latest events from Smoltek
- Heavily oversubscribed rights issue and strategic partnerships drive industrial scale-up.SMOL
Q2 2026 - Nanotechnology platform delivers cost-effective capacitors and hydrogen electrodes for high-growth markets.SMOL
AGM 2026 presentation - Net sales fell to zero, but operational progress and new financing support ongoing industrialization.SMOL
Q1 2026 - Sales fell and losses continued, but commercialization and partnerships advanced.SMOL
Q4 2025 - Strategic tech progress and robust funding drive growth amid continued R&D investment.SMOL
Q3 2025 - Losses continued amid R&D focus, but key tech and financing milestones accelerated commercialization.SMOL
Q2 2025 - Net loss narrowed and technical breakthroughs achieved, but revenue fell to zero.SMOL
Q3 2024 - Reduced losses, new capital, and strategic asset sale process mark a pivotal Q2 for Smoltek.SMOL
Q2 2024 - Smoltek secured key financing and tech milestones in Q1 2025, advancing toward commercialization.SMOL
Q1 2025